David A. Siegel Avanos Medical, Inc. Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 34,700 shares of AVNS stock, worth $408,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,700

Previous 51,300 32.36%

Holding current value

$408,072

Previous $735,000 42.31%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$12.03 - $14.52 $199,698 - $241,032	-16,600 Reduced 32.36%	34,700 $424,000
Q1 2025 May 15, 2025	SELL	$13.95 - $17.45 $182,745 - $228,595	-13,100 Reduced 20.34%	51,300 $735,000
Q4 2024 Feb 14, 2025	SELL	$15.58 - $23.61 $310,042 - $469,839	-19,900 Reduced 23.61%	64,400 $1.03 Million
Q3 2024 Nov 14, 2024	SELL	$19.21 - $24.69 $1.15 Million - $1.48 Million	-60,100 Reduced 41.62%	84,300 $2.03 Million
Q2 2024 Aug 14, 2024	BUY	$17.85 - $20.42 $144,585 - $165,402	8,100 Added 5.94%	144,400 $2.88 Million
Q1 2024 May 15, 2024	SELL	$17.97 - $22.68 $75,474 - $95,256	-4,200 Reduced 2.99%	136,300 $2.71 Million
Q4 2023 Feb 14, 2024	SELL	$17.64 - $22.99 $666,792 - $869,021	-37,800 Reduced 21.2%	140,500 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$19.93 - $26.31 $1.09 Million - $1.44 Million	54,600 Added 44.14%	178,300 $3.61 Million
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $428,070 - $588,620	-19,000 Reduced 13.31%	123,700 $3.16 Million
Q1 2023 May 15, 2023	SELL	$26.92 - $31.75 $1.53 Million - $1.81 Million	-57,000 Reduced 28.54%	142,700 $4.24 Million
Q4 2022 Feb 14, 2023	SELL	$19.88 - $27.37 $783,272 - $1.08 Million	-39,400 Reduced 16.48%	199,700 $5.4 Million
Q3 2022 Nov 14, 2022	SELL	$21.56 - $29.59 $758,912 - $1.04 Million	-35,200 Reduced 12.83%	239,100 $5.21 Million
Q2 2022 Aug 15, 2022	SELL	$24.87 - $34.68 $756,048 - $1.05 Million	-30,400 Reduced 9.98%	274,300 $7.5 Million
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $225,186 - $279,006	7,800 Added 2.63%	304,700 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$29.25 - $36.02 $541,125 - $666,370	-18,500 Reduced 5.87%	296,900 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$31.2 - $38.5 $9.84 Million - $12.1 Million	315,400 New	315,400 $9.84 Million
Q3 2019 Nov 14, 2019	SELL	$32.06 - $44.0 $484,106 - $664,400	-15,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$37.68 - $46.52 $1.66 Million - $2.05 Million	-44,000 Reduced 74.45%	15,100 $659,000
Q1 2019 May 15, 2019	SELL	$39.84 - $51.04 $661,344 - $847,264	-16,600 Reduced 21.93%	59,100 $2.52 Million
Q4 2018 Feb 14, 2019	SELL	$41.16 - $66.67 $177,687 - $287,814	-4,317 Reduced 5.4%	75,700 $3.39 Million
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $4.41 Million - $5.81 Million	80,017 New	80,017 $5.48 Million

Others Institutions Holding AVNS

# of Institutions

308

Shares Held

42.9M

Call Options Held

Put Options Held

21.8K

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $547M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account